Skip to main content
CorWave Wins 2021 Healthtech Award
https://www.corwave.com/wp-content/uploads/2021/10/20211019-PR_Healthtech-Awards-v5fin_website.pdf
CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting
https://www.corwave.com/wp-content/uploads/2021/06/20210614-PR_In-Vivo_90_Days.pdf
CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation
https://www.corwave.com/wp-content/uploads/2021/04/20210427_CorWave_PR_ISHLT.pdf
CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor
https://www.corwave.com/wp-content/uploads/2021/01/PR_Series-C_EN_.pdf
CorWave Secures a €500,000 Grant From the Paris Region for Its Industrial Facilities
https://www.corwave.com/wp-content/uploads/2020/11/20201119_CorWave_PR_Relance_Industrie.pdf
CorWave Reports Two Critical Technical Milestones Required to Proceed to the Clinical Phase at the American Society for Artificial Internal Organs Annual Meeting
https://www.corwave.com/wp-content/uploads/2020/06/20200610_CorWave_PR_EN_2-milestones_ASAIO-Top-Abstract.pdf
CorWave Appoints Jim Schuermann as an Independent Director
https://www.corwave.com/wp-content/uploads/2020/02/20200211_corwave_pr_en_js-appointment.pdf